Unilateral Interstitial Opacities: Diagnostic Approach and Management

Critical Initial Assessment

The American College of Chest Physicians recommends excluding infection first, obtaining a detailed history of fever, productive cough, purulent sputum, and immunosuppression status, including HIV with CD4 count, chronic hepatitis C, organ transplantation, and recent chemotherapy 1
Malignancy is a primary concern, and any persistent unilateral opacity, particularly in smokers or those with risk factors, requires exclusion of primary lung cancer or metastatic disease 2
Medication history is essential, specifically asking about molecular targeting agents, immune checkpoint inhibitors, mycophenolate mofetil, and recent chemotherapy, as drug-induced pneumonitis can present asymmetrically 1
Smoking status matters, as current or former smokers may have respiratory bronchiolitis-ILD or desquamative interstitial pneumonia, though these typically present bilaterally 3, 1

CT chest without contrast is mandatory, as chest radiograph alone has poor sensitivity (27-43.5%) for detecting early pneumonia and cannot adequately characterize interstitial patterns 2
Obtain CT immediately if the patient has persistent respiratory symptoms, SpO2 <92%, significant comorbidities, advanced age, immunocompromised status, or any diagnostic delay could be life-threatening 2
Infectious evaluation, including respiratory nucleic acid detection for atypical pathogens, sputum or bronchoscopy for Pneumocystis jirovecii pneumonia (PCP), tuberculosis, and fungal organisms in immunocompromised patients, is crucial 1
Blood cultures should be obtained before antibiotics but do not delay treatment if clinical pneumonia is suspected 2

Bacterial pneumonia should be suspected if fever, productive cough, purulent sputum, leukocytosis, and rales are present, and empiric antibiotics should be initiated immediately without waiting for culture results or advanced imaging 2
Atypical pneumonia may show minimal radiographic findings despite significant symptoms 2
Tuberculosis should be considered in patients with risk factors, chronic symptoms, and upper lobe predominance 1

Initiate empiric antibiotics immediately if clinical pneumonia is suspected, without waiting for culture results or advanced imaging 2
Hospitalize if SpO2 <92%, severe respiratory distress, inability to maintain oral intake, or multilobar involvement 2
For organizing pneumonia (cryptogenic or drug-induced), corticosteroids are the mainstay of treatment 1
Do not routinely use corticosteroids for suspected infection until infectious etiologies are excluded 1

Repeat CT is essential to document resolution or progression, particularly to exclude underlying malignancy 2
Persistent opacity after appropriate treatment mandates tissue diagnosis 2
Do not rely solely on negative or equivocal chest radiograph to exclude pneumonia in patients with high clinical suspicion, as CXR misses pneumonia in 21-56% of cases confirmed by CT 2
Do not delay antibiotics waiting for CT results if clinical pneumonia is suspected 2
Do not assume bilateral disease is required for idiopathic interstitial pneumonias, as asymmetric or unilateral presentations can occur early in disease course 3, 5
Do not overlook malignancy, as any persistent unilateral opacity requires definitive exclusion of cancer 2